All
POLL: Are You Attending the 2023 Society for Pediatric Dermatology Meeting?
The 2023 Society for Pediatric Dermatology Meeting kicks off in Asheville, North Carolina, on July 13.
Spesolimab Effective in Treating Generalized Pustular Psoriasis Flares
Boehringer Ingelheim announced that novel antibody treatment can interfere in the IL-36 signaling pathway, reducing flares.
Laura Bush, DMSc, PA-C, DFAAPA, Appointed Next President of SDPA
Bush revealed what she is looking forward to in the coming year and the goals she wants to accomplish.
AD Patient Self-Confidence and Satisfaction Improved With Dupilumab Self-Injection
Dupilumab self-injection has been available to patients in Japan since May 2019.
Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma
Compared to patients without melasma, blue light irradiation caused minimal changes in patients with melasma.
POLL: Do You Treat More Male or Female Patients With Melanoma?
Click here to answer this week's poll.
Researchers Study Possible Link Between Atopic Dermatitis and Tooth Agenesis
Examining the genes and signaling pathways of development of atopic dermatitis and tooth agenesis reveals possible link between the two diseases.
Hidradenitis Suppurativa Treated with Sonelokimab Shows Significant Improvement
In a clinical trial, patients reported improved quality of life after 12 weeks on sonelokimab.
Dupilumab Effective in Reducing New Allergies and Slowing Atopic March
Findings indicate no rebound effect when participants discontinue dupilumab.
Intelligent Scalpel Uses Artificial Intelligence to Increase Safety of Surgery
Steven Hacker, MD, explains how the electromagnetic resonant scalpel provides a digitized record of the in vivo scalpel path.
The Weekly Roundup: July 2-8
ICYMI, this week we had stories about burn management and treatment in light of the July 4 holiday, pearls from the 2023 World Congress of Dermatology meeting in Singapore, acral lentiginous melanoma in AAPI patients, and more.
Molecular Differentiation of Dermatologic Therapeutics With Christopher Bunick, MD, PhD
Bunick presented 3 sessions at the 2023 World Congress of Dermatology meeting in Singapore.
Tildrakizumab Data Reveals Significant Wellbeing Improvement in Patients With Plaque Psoriasis
Data presented in a poster presentation at the 2023 World Congress of Dermatology meeting in Singapore showed significant improvements to patient quality of life.
PMC48 Probiotic Strain Demonstrates Promise in Hyperpigmentation
Pediococcus acidilactici demonstrated significant clinical efficacy and potential in treating hyperpigmentation.
Partner with Hair Stylists and Give Them the Knowledge to Spot Scalp Concerns
The HEROES program wants to make it easier for stylists to recognize scalp conditions and advise their clients to seek medical help.
Multi-Peptide Eye Serum Reduces Number of Lines and Wrinkles
The study found that using the multi-peptide eye serum twice a day resulted in improved elasticity and firmness.
Kidney Disease-Associated Pruritus and Managing Prurigo Nodularis: Treatment Pearls From Raj Chovatiya, MD, PhD
As the 25th World Congress of Dermatology winds down this week, Chovatiya shares highlights from his sessions in Singapore.
Acral Lentiginous Melanoma More Common in Southeast Asian Patients Than Other Asian American & Pacific Islander Groups
A poster presentation from the 19th Annual Skin of Color Society Scientific Symposium analyzed the differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.
Facial Squamous Cell Carcinomas Successfully Treated with Topical Solution and Laser Therapy
Aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light achieves positive results in treating squamous cell carcinoma.
Oral Treatment of Plaque Psoriasis Achieves Primary and Secondary Endpoints in Trial
Janssen Pharmaceutical Companies announced its oral treatment for moderate to severe plaque psoriasis will be taken to Phase 3 clinical trials.
Eczema Associated With Heightened Risk of Peanut Allergy in Infants
Pediatric patients with moderate to severe eczema demonstrated an increased risk of experiencing the food allergy.
Established Georgia DermPA™ Becomes SDPA’s Board President
6 Months in Review: Vitiligo in the First Half of 2023
As we have surpassed the halfway mark of 2023, Dermatology Times is spotlighting vitiligo coverage and news from the first half of year.
A Snapshot of the Correlation Between Acne, Social Media, and Mental Health
The American Acne and Rosacea Society brings attention to the negative emotional effects of acne.
Alan Mendelsohn, MD, Reviews Phase 3 TMB-001 PK Data for Congenital Ichthyosis
New pharmacokinetic phase 3 data will be presented at the 2023 Society for Pediatric Dermatology meeting next week.
Ruxolitinib Granted Marketing Authorization in United Kingdom
The authorization comes just over 2 months after the drug’s approval in the European Union.
Plaque Psoriasis Symptoms Improved With Deucravacitnib Treatment
Investigators reported that deucravacitnib improved quality of life and clinical outcomes scores in those with moderate to severe psoriasis.
Trained Immunity May Play a Role in the Pathogenesis of Vitiligo
Trained immunity may act as an enhancer and continuous trigger in the disease’s pathogenesis.
Pointers With Portela: Interview With Ron Robinson
In this week’s Pointers With Portela, the 208SkinDoc interviews Ron Robinson, a well-known cosmetic chemist in the skin care industry.
Study Review Finds Vitamin C is Effective in Treating Signs of Photoaging
Studies found that skin treated with vitamin C was smoother and less wrinkled than skin treated with a placebo.
